Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
Singapore Court Allows $2.7 Billion 1MDB Lawsuit Against Standard Chartered to Proceed 
Afghan Suspect in Deadly Shooting of National Guard Members Faces First-Degree Murder Charge 
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback 
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut 
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit 
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Federal Judge Blocks Trump Administration’s Medicaid Funding Restrictions Targeting Planned Parenthood 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment 
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
A US Court of Appeals revived a challenge by Johnson & Johnson unit Auris Health Inc to a patent on a robotic tool used to perform surgery held by rival Intuitive Surgical Operations Inc.
The US Patent Trial and Appeal Board (PTAB) found that the two earlier patents included all the elements of Intuitive's. However, it said the patent was not obvious because a person of ordinary skill would not have been motivated to combine them because of skepticism at the time of the invention for using robotic systems during surgery in the first place.
A panel of the US Court of Appeals for the Federal Circuit Court ruled 2-1to direct the US Patent and Trademark Office's invention tribunal to revisit its determination that the 2012 patent, which covers a technique for more readily swapping out different surgical tools on a robotic surgical arm, was not obvious.
Auris petitioned the PTAB to invalidate Intuitive's patent in 2019, stating that it was obvious in light of two previous patents by other inventors. Those patents were for a robotic surgery interface and a robotic stand that could hold numerous instruments, respectively.
Robotic surgery uses robotic arms to manipulate surgical instruments under the supervision of a human surgeon. The technique is designed to provide surgeons with more precise control than traditional surgery.
The global robotic surgery market is expected to produce $5.46 billion in 2020, according to a report by Research and Markets. Auris is seen as a serious competitor to industry leader Intuitive.
